Firefly Neuroscience (AIFF) Operating Expenses (2010 - 2026)

Firefly Neuroscience's Operating Expenses history runs 16 years deep, the most recent figure standing at $7000.0 for Q1 2026.

• On a quarterly basis, Operating Expenses fell 99.67% year-over-year to $7000.0 in Q1 2026; TTM through Mar 2026 was $14.1 million, a 26.11% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, down 6.5% from the prior year.
• Operating Expenses eased to $7000.0 in Q1 2026 per AIFF's latest filing, from $9.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $9.3 million in Q4 2025 and bottomed at $7000.0 in Q1 2026.
• The 5-year median for Operating Expenses is $1.9 million (2022), against an average of $2.6 million.
• Across the five-year window, Operating Expenses surged 895.97% in 2024 and plunged 99.67% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $1.5 million in 2022, then grew by 3.23% to $1.6 million in 2023, then surged by 320.74% to $6.7 million in 2024, then jumped by 40.09% to $9.3 million in 2025, then tumbled by 99.93% to $7000.0 in 2026.
• Per Business Quant, the three latest AIFF Operating Expenses figures stand at $7000.0 (Q1 2026), $9.3 million (Q4 2025), and $2.8 million (Q3 2025).